Abstract 4138388: Lipoprotein(a): Real-world Impact of Assay Change

作者
Janeni Jeevanathan,Sigrid Blom,Thomas Olsen,Kirsten Bjørklund Holven,Erik Arnesen,Torleif Trydal,Børge Grønne Nordestgaard,Michael Sovershaev,Ying Chen,Kjetil Retterstøl,Jacob Juel Christensen
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:150 (Suppl_1)
标识
DOI:10.1161/circ.150.suppl_1.4138388
摘要

Background and aims: Different assays have been used to analyze lipoprotein(a) over time, and the need for standardization of Lp(a) assays is well-known. Nonetheless, the impact of the use of different assays for clinical decision making and risk stratification of individuals is understudied. We aimed to investigate how transitioning between Lp(a) assays at a large central laboratory affected the proportion of individuals with Lp(a) result above clinical thresholds. Methods: We studied nationwide clinical laboratory data from Norway including 185,493 individuals between 18-50 years of age with 272,463 Lp(a) measurements between 2000-2019. Lp(a) was analyzed in non-frozen serum samples using immunoturbidimetric methods from Roche Tina-quant assay (generation 1) in 2000–2009 (N individuals = 75,221) and Siemens LPA assay (N individuals = 123,824) in 2009-2019 in mg/dL units. Because some lipid-lowering drugs can modestly alter plasma Lp(a), the data material was restricted to individuals <50 years due to a low use of medication in this age group. Results: The Roche assay detected 35% more individuals with Lp(a) > 50 mg/dL than the Siemens assay in the total population. In individuals that had measurements analyzed by both Roche and Siemens assays (N = 13,494), the Roche assay detected 40% more individuals with Lp(a) > 50 mg/dL than the Siemens assay (25%, N = 3,373 vs. 18%, N = 2,475), and 70% more individuals with Lp(a) >85 mg/dL than the Siemens assay (11%, N = 1,478 vs. 6.5%, N = 881). Conclusion: The choice of Lp(a) immunoassay can influence interpretation of Lp(a) results and decisions, particularly in individuals approaching clinically relevant Lp(a) thresholds.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
YC完成签到,获得积分10
2秒前
研友_VZG7GZ的应助被杨瑞采纳,获得10
2秒前
CodeCraft的应助被QQ采纳,获得10
4秒前
大佐完成签到,获得积分10
4秒前
相由心生完成签到,获得积分10
5秒前
luoshiwen发布了新的文献求助10
5秒前
脆脆Shark完成签到,获得积分10
5秒前
6秒前
寻123完成签到,获得积分10
6秒前
klwy完成签到,获得积分10
6秒前
爱吃巧克力完成签到,获得积分20
6秒前
契约发布了新的文献求助10
6秒前
7秒前
7秒前
orixero的应助被yshog采纳,获得10
7秒前
lllll完成签到,获得积分10
7秒前
8秒前
喊喊发布了新的文献求助10
10秒前
galaa完成签到,获得积分10
10秒前
CMDHZ发布了新的文献求助10
11秒前
n文献o完成签到,获得积分10
13秒前
CC完成签到 ,获得积分10
13秒前
13秒前
13秒前
13秒前
14秒前
大耳朵图图完成签到 ,获得积分10
15秒前
16秒前
余香的应助被予秋采纳,获得10
16秒前
oo完成签到,获得积分10
16秒前
18秒前
18秒前
Orange的应助被红豆鲫鱼饼采纳,获得10
18秒前
yshog发布了新的文献求助10
18秒前
帅狗完成签到,获得积分10
18秒前
CipherSage的应助被小丑恐龙采纳,获得20
19秒前
19秒前
大筒木因陀罗完成签到 ,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193348
求助须知:如何正确求助?哪些是违规求助? 9579548
关于积分的说明 21866040
捐赠科研通 7792906
什么是DOI,文献DOI怎么找? 3437242
关于科研通互助平台的介绍 2560702
邀请新用户注册赠送积分活动 2484066